Description

DESCRIPTION

Elopag is a prescription drug used for the treatment of Thrombocytopenia in patients with Chronic ITP, Thrombocytopenia in patients with Hepatitis C infection and Severe Aplastic Anemia.

ADDITIONAL INFORMATION

Brand Name: ELOPAG
Generic Name :ELTROMBOPAG
Strengths available : 25 mg , 50 mg
Form : Tablets
PACK SIZE
Bottle of 14 tablets
Manufacturer : Everest Pharmaceuticals Ltd

Dosage : Recommended dosage for Thrombocytopenia in patients with Chronic ITP– (Initial Dose Regimen) : (Adult and Pediatric Patients 6 Years and Older with ITP) Initiate Elopag at a dose of 50 mg once daily, except in patients who are of Asian ancestry (such as Chinese, Japanese, Taiwanese, or Korean) or who have mild to severe hepatic impairment (Child-Pugh Class A, B, C).For patients of Asian ancestry with ITP, initiate Elopag at a reduced dose of 25 mg once daily.

For patients with ITP and mild, moderate, or severe hepatic impairment (Child-Pugh Class A, B, C), initiate Elopag at a reduced dose of 25 mg once daily. For patients of Asian ancestry with ITP and hepatic impairment (Child-Pugh Class A, B, C), consider initiating Elopag at a reduced dose of 12.5 mg once daily.

Pediatric Patients with ITP Aged 1 to 5 Years– Initiate Elopag at a dose of 25 mg once daily.

Recommended dosage for Thrombocytopenia in patients with Hepatitis C infection –(Initial Dose Regimen)- Initiate Elopag at a dose of 25 mg once daily.

Recommended dosage for Severe Aplastic Anemia- (Initial Dose Regimen)– Initiate Elopag at a dose of 50 mg once daily.

SIDE EFFECTS

Common side effects are insomnia, dizziness, headache, cough, dyspnea, nausea, oropharyngeal pain, rhinorrhea, abdominal pain, diarrhea, ecchymosis, transaminases increased, arthralgia, muscle spasms, pain in extremity, febrile neutropenia, pyrexia and fatigue.